2026 Annual Meeting | C164 - Neuromyelitis Optica Spectrum Disorders

Date Wednesday 04/22/26

Time 07:00 AM - 09:00 AM CDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Kelsey Poisson, MD

Topic(s) Multiple Sclerosis

Learning Objectives Participants should become familiar with the diagnostic criteria and clinical presentations of NMOSD, recognize the MRI features of this disorder, identify the unique aspects of pediatric NMOSD care, and apply evidence-based treatment approaches to difficult cases.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Neurohospitalist, Medical Student

Teaching Styles Case-based, Didactic

Event Timeline
07:00 AM - 07:05 AM CDT	Introduction	Introduction Kelsey Poisson, MD
07:05 AM - 07:45 AM CDT	Speaker	Clinical-MRI Manifestations and Diagnosis of NMOSD Elia Sechi, MD
07:45 AM - 08:10 AM CDT	Speaker	Pediatric NMOSD Kelsey Poisson, MD
08:10 AM - 08:50 AM CDT	Speaker	Treatment Conundrums in NMOSD Eoin P. Flanagan, MBBCh, FAAN
08:50 AM - 09:00 AM CDT	Q&A	Questions and Answers Kelsey Poisson, MD, Eoin P. Flanagan, MBBCh, FAAN, Elia Sechi, MD

Faculty Disclosures
Kelsey Poisson, MD	Dr. Poisson has nothing to disclose.
Eoin P. Flanagan, MBBCh, FAAN	The institution of Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. The institution of Dr. Flanagan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmacy times. The institution of Dr. Flanagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Flanagan has received research support from Viela Bio. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Roche. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has a non-compensated relationship as a Member of medical Advisory Board with The MOG Project that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Journal of The Neurologic Sciences that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Neuroimmunology Reports that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology, Neuroimmunology Neuroinflammation (N2) Journal that is relevant to AAN interests or activities.
Elia Sechi, MD	Dr. Sechi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Sechi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx.

��ɫ��

��ɫ��